Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Phase III results for HNK20

March 21, 1997

New cephalosporins from Kyoto Pharmaceutical Industries

March 21, 1997

Favorable phase III results reported for Cytolex

March 19, 1997

Natural squalene synthase inhibitors discovered by Pfizer

March 19, 1997

Pharmacokinetics and safety of BMS-180680

March 18, 1997

Roche prepares new antiviral agents

March 18, 1997

MRC, Sankyo and Oncogene Science to develop new antiflu drugs

March 14, 1997

Sequus seeks FDA approval for new indication of Amphotec

March 14, 1997

Clinical trial results for Neuprex in hepatectomy and meningococcemia

March 13, 1997

Long-acting injectable antifungal enters phase II trials

March 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...